-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on GRI Bio, Inc. (GRI)
-
-
-
-
-
-
-
GRI Bio (GRI) Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan
-
-
-
-
-
-
-
GRI Bio, Inc (GRI) Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T Cell Activity
-
-
-
-
-
-
-
GRI Bio, Inc (GRI) Prices 2.19M Share Offering at $1.83/sh
-
-
408,923 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

